Don’t Jump to Voquezna for Erosive GERD
Rx vonoprazan (Voquezna) will be touted as the first acid suppressant with a new mechanism of action in over 30 years.
It’s the first potassium-competitive acid blocker (PCAB)...and is now approved for erosive esophagitis.
Think of vonoprazan as a “fancy PPI”...with some differences.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote